"Neurofibromatoses" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A group of disorders characterized by an autosomal dominant pattern of inheritance with high rates of spontaneous mutation and multiple neurofibromas or neurilemmomas. NEUROFIBROMATOSIS 1 (generalized neurofibromatosis) accounts for approximately 95% of cases, although multiple additional subtypes (e.g., NEUROFIBROMATOSIS 2, neurofibromatosis 3, etc.) have been described. (From Neurochirurgie 1998 Nov;44(4):267-72)
Descriptor ID |
D017253
|
MeSH Number(s) |
C04.557.580.600.580.590 C04.700.645 C10.562.600 C10.574.500.549 C16.320.400.560 C16.320.700.645
|
Concept/Terms |
Neurofibromatoses- Neurofibromatoses
- Neurofibromatosis
- Neurofibromatosis Syndrome
- Neurofibromatosis Syndromes
- Syndrome, Neurofibromatosis
- Syndromes, Neurofibromatosis
- Multiple Neurofibromas
- Multiple Neurofibroma
- Neurofibroma, Multiple
- Neurofibromas, Multiple
Neurofibromatosis 3- Neurofibromatosis 3
- Neurofibromatosis 3s
- Neurofibromatosis Type 3
- Neurofibromatosis Type 3s
- Type 3, Neurofibromatosis
|
Below are MeSH descriptors whose meaning is more general than "Neurofibromatoses".
Below are MeSH descriptors whose meaning is more specific than "Neurofibromatoses".
This graph shows the total number of publications written about "Neurofibromatoses" by people in this website by year, and whether "Neurofibromatoses" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 1 | 0 | 1 |
2001 | 1 | 0 | 1 |
2006 | 1 | 0 | 1 |
2010 | 1 | 0 | 1 |
2013 | 1 | 0 | 1 |
2015 | 1 | 0 | 1 |
2016 | 1 | 0 | 1 |
2017 | 1 | 0 | 1 |
2018 | 2 | 0 | 2 |
2020 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Neurofibromatoses" by people in Profiles.
-
Recurrent Schwannomatosis of the Hand. Hand (N Y). 2020 09; 15(5):732-738.
-
2016 Children's Tumor Foundation conference on neurofibromatosis type 1, neurofibromatosis type 2, and schwannomatosis. Am J Med Genet A. 2018 05; 176(5):1258-1269.
-
Mobility Functional Outcomes of Neurofibromatosis Patients: A Preliminary Report. Am J Phys Med Rehabil. 2018 Jan; 97(1):41-49.
-
Cancer and Central Nervous System Tumor Surveillance in Pediatric Neurofibromatosis 1. Clin Cancer Res. 2017 Jun 15; 23(12):e46-e53.
-
Creation of an international registry to support discovery in schwannomatosis. Am J Med Genet A. 2017 Feb; 173(2):407-413.
-
The effect of chemotherapy on optic pathway gliomas and their sub-components: A volumetric MR analysis study. Pediatr Blood Cancer. 2015 Aug; 62(8):1353-9.
-
Neurofibromatosis of the head and neck: classification and surgical management. Plast Reconstr Surg. 2015 Mar; 135(3):845-855.
-
Melanocytic differentiation is present in a significant proportion of nonpigmented diffuse neurofibromas: a potential diagnostic pitfall. Am J Surg Pathol. 2013 Aug; 37(8):1182-91.
-
Back to the future: proceedings from the 2010 NF Conference. Am J Med Genet A. 2011 Feb; 155A(2):307-21.
-
Segmental neurofibromatosis in association with a large congenital nevus and malignant melanoma. Dermatol Online J. 2006 Dec 10; 12(7):22.